AAIC 2025 Abstract
CSF Proteome Analysis of p ‐Tau181 and Other Alzheimer's Disease Biomarkers Identifies Autotaxin–Lysophosphatidic Acid Signaling as Potential Therapeutic Targets
Study in peopleMechanisms
Abstract
Background: We investigated the relationship between the cerebrospinal fluid (CSF) proteome in Alzheimer's disease (AD) and the clinical and biomarker‐assisted diagnoses, and with CSF biomarker levels of AD.
